News Tag: 2020 newsletters
Adding Peposertib to Radiotherapy for Patients with Advanced Head and Neck Cancer Who are Cisplatin-Ineligible (NRG-HN008)
Read More
Unique Trial Combines Concurrent Immunotherapy and Radiation Therapy to Determine if this Treatment Option Improves Survival Outcomes for Patients with Limited-Stage Small Cell Lung Cancer (NRG-LU005)
Read More
Exploring the Addition of Nivolumab to Platinum-Gemcitabine for Recurrent or Metastatic Nasopharyngeal Cancer (NRG-HN007)
Read More
Breast Cancer Awareness Month: Why it Matters
Read More
NRG Oncology Health Disparities Committee (HDC) Update (9/14/2020)
Read More
Can Immunotherapy Improve Outcomes for Patients with MGMT Unmethylated Glioblastoma on NRG-BN007?
Read More
The Raptor Trial (NRG-LU007) for Extensive Stage Small Cell Lung Cancer
Read More
A New Trial in Localized High Risk Prostate Cancer (GU009) is Opening Soon!
Read More
Randomized phase III trial of radiation therapy with or without pembrolizumab for women with high intermediate risk mismatch repair deficient (dMMR) endometrioid endometrial cancer (NRG-GY020)
Read More
Calling all NRG Oncology Investigators! NRG-GY022 is open for ANY cancer patient undergoing carboplatin treatment, any cycle!
Read More